COVID-19: our experience and quality of management analysis: (Topolsica Hospital case report)
Zdravniski Vestnik
; 92(3/4):149-153, 2023.
Article
in English
| CAB Abstracts | ID: covidwho-20239160
ABSTRACT
Various Slovenian hospitals were recruited to treat COVID-19 patients in Slovenia during the COVID-19 epidemic. Centrally coordinated hospital utilisation - depending on the needs, available hospital bed capacity, and considering the professional orientation of individual hospitals - left these facilities with different experiences. We present our experience and COVID-19 treatment management during the fourth epidemic wave in our peripheral, pulmonary-oriented hospital, representing the first treatment quality analysis of these patients in Slovenia. The basic hospitalization characteristics were analysed using integrated Birpis information system solutions and the electronic temperature-therapeutic charts (eTTL) review. The quality of management was assessed through adherence to professional recommendations. The analysis was carried out with the in-built statistical functions of Microsoft Excel software. 99 patients (58 women, 41 men) aged 67.9 years were hospitalised for an average of 8.1 days. The majority were residents of our region (61%), unvaccinated (61.6%), and experienced a severe form of the disease with the need for oxygen supplementation (88.9%). The majority received steroids (73.7%), antibiotics (68.7%) and vitamin D (71.7%), to a lesser extent specific therapy (remdesivir 25.3%, combination casirivimab/imdevimab 2%, tocilizumab 1%). No adverse reactions were noted. 17 people died (total mortality rate 17.2%). There was no infection transmission among the COVID department staff. Results show successful treatment of patients with COVID-19 in Topolsica Hospital. They also suggest the possibility of further improvements, particularly in prescribing antibiotic therapy.
Prion; Viral; Bacterial and Fungal Pathogens of Humans [VV210]; Health Services [UU350]; Pesticides and Drugs; Control [HH405]; human diseases; coronavirus disease 2019; hospitals; viral diseases; clinical aspects; disease course; drug therapy; tocilizumab; man; Severe acute respiratory syndrome coronavirus 2; Slovenia; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; Balkans; Southern Europe; Europe; Central Europe; European Union Countries; high income countries; Mediterranean Region; very high Human Development Index countries; SARS-CoV-2; viral infections; clinical picture; disease progression; chemotherapy
Full text:
Available
Collection:
Databases of international organizations
Database:
CAB Abstracts
Type of study:
Case report
/
Qualitative research
Language:
English
Journal:
Zdravniski Vestnik
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS